Ordinance
on Licensing in the Medicinal Products Sector
(Medicinal Products Licensing Ordinance, MPLO)


Open article in different language:  DE  |  FR  |  IT
Art. 25 Due diligence

1 Hold­ers of a li­cence in ac­cord­ance with Art­icle 24 must en­sure that the sup­pli­er and the cus­tom­er are au­thor­ised to carry out the work pro­cesses that they per­form. They must be able to prove this.

2 They must en­sure that the medi­cin­al products have not ori­gin­ated from il­leg­al trad­ing and are not in­ten­ded for un­law­ful pur­poses.

3 They must for­ward to the cus­tom­er or the sup­pli­er all in­form­a­tion provided by any sup­pli­er or cus­tom­er re­gard­ing the qual­ity and safety of the medi­cin­al product or that is rel­ev­ant for the au­thor­it­ies, in par­tic­u­lar in­form­a­tion about medi­cin­al product re­calls.

4 The agents must ad­di­tion­ally re­tain cop­ies of the pa­per­work doc­u­ment­ing the busi­ness trans­ac­tion.

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden